Marketing to Scientists Requires Careful Segmentation
13 Dezember 2005 - 7:06PM
PR Newswire (US)
ARLINGTON, Va., Dec. 13 /PRNewswire/ -- While scientists routinely
exhibit similar product and technology preferences, how they prefer
to find out about these offerings varies according to market
segment, age, years of research experience, job position and
gender. A new report from market research and consulting firm
BioInformatics, LLC (http://www.gene2drug.com/) explores the media
preferences of more than 2,000 life scientists who answered a 49-
question survey relating to Web sites, product catalogs, email
marketing, advertising, direct mail and exhibits at conferences.
"Suppliers to the life science market routinely practice
segmentation when introducing products for specific applications,"
observes Tamara Zemlo, Ph.D., MPH, Director of Syndicated Research
at BioInformatics, LLC. "But it's less common for them to use
segmentation when developing their marketing communications
strategy." "Marketing to Life Scientists: Navigating Channels
Through Segmentation," is the latest edition of an annual survey
that first began tracking customer preferences and the performance
of corporate marketing in 1997. For the first time, it utilizes the
results of CHAID analysis (Chi-squared Automatic Interaction
Detector), an advanced statistical technique used for identifying
the key drivers or influences in defined markets. "We created a
survey that would allow us to examine the data by any combination
of survey variables: demographic, behavioral or attitudinal. The
results of these analyses will help suppliers determine which
communications channels and messages appeal to which niche
markets," says Zemlo. The report clearly demonstrates the
complexity of marketing to life scientists. While on one hand
scientists strongly indicated their preference for Web sites, the
traditional channels of exhibiting at scientific conferences,
printed catalogs and direct mail remain the most common ways
scientists learn about suppliers and their products. "The need to
allocate resources across multiple channels is very clear, and
understanding customer media preferences helps deliver the right
message to those most inclined to take notice," explains Zemlo.
"For example, of the respondents who would read email messages from
vendors, 27% would most like to receive an announcement about
discounts, while another 28% want to hear about new products. We
also observed trends in their preferences such as the fact that
last year, 28% of scientists surveyed said that they would throw
away a catalog that they had not requested -- this percentage has
risen to 40% in 2005." The scientists also ranked the effectiveness
of their suppliers' marketing programs in terms of "best" Web site,
print catalog, exhibits, print advertising and sales force. While
hundreds of companies were mentioned, market leaders such as
Bio-Rad (AMEX:BIO), Fisher Scientific (NYSE:FSH), Invitrogen
(NASDAQ:IVGN), Sigma-Aldrich (NASDAQ:SIAL), New England Biolabs and
VWR International all received exceptionally high rankings in
multiple categories. Zemlo concludes, "Segmentation in support of
marketing is going to become increasingly important as
communication channels proliferate. The respondents to our survey
submitted more than 60 pages of comments in response to an open-
ended question about new media such as blogs, podcasts and
videocasts. As a new generation of scientists emerges, vendors will
have to integrate new and traditional media into their marketing
campaigns." For a complimentary Executive Summary of this report,
please visit http://www.gene2drug.com/reports. ABOUT
BIOINFORMATICS, LLC BioInformatics, LLC is a market research firm
located in Arlington, Virginia. BioInformatics supports marketing,
sales and R&D executives in the life science, medical device
and pharmaceutical industries through published research reports,
custom research and consulting. BioInformatics sponsors the world's
largest market research panel of scientific customers -- The
Science Advisory Board (http://www.scienceboard.net/) -- which
consists of more than 27,000 scientists, physicians and other life
science and medical professionals from 62 countries who participate
in surveys that address emerging technologies, test customer
reactions to new product concepts, measure brand awareness and
assess advertising effectiveness. For more information, please
contact: Amanda Donathen BioInformatics, LLC 2111 Wilson Blvd.,
Suite 250 Arlington, VA 22201 703.778.3080 x14 (phone) 703.778.3081
(fax) http://www.gene2drug.com/ DATASOURCE: BioInformatics, LLC
CONTACT: Amanda Donathen of BioInformatics, LLC, +1-703-778-3080
x14, or Web site: http://www.gene2drug.com/
http://www.scienceboard.net/
Copyright
Fisher Scientific (NYSE:FSH)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Fisher Scientific (NYSE:FSH)
Historical Stock Chart
Von Jan 2024 bis Jan 2025